Navigation Links
Glycerin Proven to Improve Bruising and Swelling Caused By Trauma to Skin
Date:5/15/2009

and skin types. Bruise Relief (TM) gel is available nationwide at all CVS stores as well as at Jewel/Osco, Albertsons, Acme, Shaw's and other fine pharmacies across the country.

"Bruise Relief(TM) has been in my family for nearly five generations," said Barbara Cranner, executive vice president of Dr. Holmquist Healthcare, LLC. "We developed the product for the mass market with my stepfather, Dr. Nelson Holmquist, and we are thrilled to share an old family recipe with the world."

About Dr. Holmquist Healthcare, LLC

Dr. Holmquist Healthcare, LLC is a family- and majority-woman-owned and operated company. Headquartered in Mandeville, Louisiana, the company is dedicated to the revitalization of New Orleans, and manufactures the company's product lines at local plants. Dr. Holmquist Healthcare's product line currently features Bruise Relief(TM), a topical skin care product in a gel and serum formulation designed to eliminate the appearance of bruising and skin discoloration. Learn more about Dr. Holmquist Healthcare and its products at http://www.bruiserelief.com.

CONTACT: Holly Campbell, Levick Strategic Communications, +1-202-973-1337, hcampbell@levick.com


'/>"/>
SOURCE Dr. Holmquist Healthcare, LLC
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Data Presented at AUA Demonstrate PROVENGE Significantly Prolongs Survival for Men With Advanced Prostate Cancer in Pivotal Phase 3 IMPACT Study
2. Dendreon to Hold a Conference Call Tomorrow at 9:00 AM ET to Discuss Final Results of Phase 3 PROVENGE IMPACT Trial
3. Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial
4. Dendreon to Hold a Conference Call Today at 9:00 AM ET to Provide an Update on Interim Results of Phase 3 PROVENGE IMPACT Trial
5. Derma Sciences MEDIHONEY(TM) Proven to Speed Healing in Stalled Leg Ulcers
6. Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October
7. Dendreon Initiates Phase 2 Trial of PROVENGE in Patients With Localized Prostate Cancer Prior to Surgery
8. Clinically Proven Treatment Offers Help to Rosacea Sufferers
9. Controversial Shoulder Surgery for First-time Dislocation Proven Effective Long-Term
10. Study Shows: New Blood Test Proven Six Times More Effective For Tuberculosis Control
11. Dendreon Presents Data Correlating the Cumulative Potency of PROVENGE(R) to Overall Survival
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... May 27, 2015 E-QURE, Corp. ... engaged in the development and commercialization of its Bio-electrical ... electrotherapy for the noninvasive treatment of hard to heal ... Zacks Small Cap Research http://scr.zacks.com issued a ... According to Zacks, research update, E-QURE Corp "…has a ...
(Date:5/27/2015)... Medical Device Contract Manufacturing - new study ... Where is the market for medical device ... for this market and medical device outsourcing ... you potential revenues and other trends to 2025, discussing ... report provides 127 tables, charts, and graphs. Discover the ...
(Date:5/27/2015)... 27, 2015  Foundation Health Care  (FDNH), which owns ... services, announced today it will present at the LD ... at Luxe Sunset Boulevard Hotel, Los Angeles, ... June 2 nd at 3:00pm and will also ... meeting please contact LD Micro. For more information about ...
Breaking Medicine Technology:Zacks Investment Small Cap Research Issues Quarterly Update on E-QURE 2Zacks Investment Small Cap Research Issues Quarterly Update on E-QURE 3Medical Device Contract Manufacturing Market Forecast 2015-2025 2Medical Device Contract Manufacturing Market Forecast 2015-2025 3Medical Device Contract Manufacturing Market Forecast 2015-2025 4Medical Device Contract Manufacturing Market Forecast 2015-2025 5Medical Device Contract Manufacturing Market Forecast 2015-2025 6Medical Device Contract Manufacturing Market Forecast 2015-2025 7
... A new visual evoked potential method has been ... with ocular and/or neurological conditions. The research team of ... at the SUNY State College of Optometry, Department of ... called "Effect of Different Stimulus Configurations on the Visually ...
... YORK, Aug. 2, 2011 Hadasit Bio-Holdings, Ltd. ... biotech companies, all based on intellectual property developed ... medical research center, and its subsidiary, BioMarCare Technologies ... Research and Development (BIRD) Foundation has given initial ...
Cached Medicine Technology:A New, Objective Way to Assess Visual Fields: Visual Evoked Potentials 2A New, Objective Way to Assess Visual Fields: Visual Evoked Potentials 3BioMarCare Technologies Ltd. Receives a $900k Grant for a Joint Project with Ariadne Inc. 2BioMarCare Technologies Ltd. Receives a $900k Grant for a Joint Project with Ariadne Inc. 3
(Date:5/27/2015)... 27, 2015 SAN DIEGO, May ... Mississippi, is the first healthcare provider along the ... chronic care management (CCM). In partnership with MD ... introducing RevUp, a new program that enables healthcare ... increase monthly reimbursements. This new, user-friendly program is ...
(Date:5/27/2015)... Cincinnati Veterans Affairs Women’s Health Clinic in ... Foundation is proud to host the first annual Women Veterans ... 11 at the Freedom Center from 6 p.m. to 10 ... emcee. , This event honors and celebrates women tri-state ... The banquet is free to the first 150 women Veterans ...
(Date:5/27/2015)... 27, 2015 “Heroin has never been more ... overdoses are coming from,” says Harford County Sheriff Jeff Gahler, ... 8th. In the surging heroin related incidents in Baltimore, police ... education to prevent heroin addiction and subsequent abuse before it ... Drug Rehab Baltimore is a drug and alcohol rehab facility ...
(Date:5/27/2015)... Oregon (PRWEB) May 27, 2015 ... in North America, is offering free design advice to ... outside environment. , “Light pollution caused by streetlights, ... cause a restless night’s sleep, said Kim Rush, VP ... of numerous cities across North America with recently installed ...
(Date:5/27/2015)... TX (PRWEB) May 27, 2015 Congratulations ... The Torch” Addiction Treatment Scholarship Award. From June 1, ... $10,000 to 50 drug and alcohol addiction treatment centers ... treatment. Scholarships were drawn at random at addiction treatment ... for Sky Toxicology, Matt Green said, “Sky Toxicology would ...
Breaking Medicine News(10 mins):Health News:Memorial Hospital Selects MD Revolution's Digital Health Platform to Deliver a New Form of Chronic Care Management 2Health News:Memorial Hospital Selects MD Revolution's Digital Health Platform to Deliver a New Form of Chronic Care Management 3Health News:Cincinnati VA Women’s Health Clinic Celebrates Women Veterans at Awards Banquet 2Health News:The Price of Heroin in Baltimore Drops, Surging Use and Causing Rife Overdose Deaths 2Health News:The Price of Heroin in Baltimore Drops, Surging Use and Causing Rife Overdose Deaths 3Health News:Decorview Helps Homeowners Combat Light Pollution 2Health News:Sky Toxicology Reaches Their $500,000 Goal in Drug and Alcohol Addiction Treatment Patient Scholarship Awards 2Health News:Sky Toxicology Reaches Their $500,000 Goal in Drug and Alcohol Addiction Treatment Patient Scholarship Awards 3
... hospitals to vaccinate all children , MONDAY, March 8 (HealthDay ... with hepatitis B aren,t getting treatments that have been shown ... , Given within 24 hours of birth, the hepatitis B ... 95 percent of newborns from becoming infected, even if they ...
... , ... ... , ... , , ...
... ... ... ... ...
... , ... ... ... ...
... , ... ... ... ...
... ... ... ... ...
Cached Medicine News:Health News:1 in 5 At-Risk U.S. Babies Doesn't Get Hepatitis B Vaccine 2Health News:1 in 5 At-Risk U.S. Babies Doesn't Get Hepatitis B Vaccine 3Health News:World Cocoa Foundation Launches Cocoa Livelihoods Program in Nigeria 2Health News:World Cocoa Foundation Launches Cocoa Livelihoods Program in Nigeria 3Health News:World Cocoa Foundation Launches Cocoa Livelihoods Program in Nigeria 4Health News:World Cocoa Foundation Launches Cocoa Livelihoods Program in Nigeria 5Health News:Roche/Genentech/Chugai's Herceptin as an Add-On to Standard Chemotherapy Will Become Decision Resources' Clinical Gold Standard in 2013 for the Treatment Of Gastric Cancer 2Health News:Roche/Genentech/Chugai's Herceptin as an Add-On to Standard Chemotherapy Will Become Decision Resources' Clinical Gold Standard in 2013 for the Treatment Of Gastric Cancer 3Health News:Roche/Genentech/Chugai's Herceptin as an Add-On to Standard Chemotherapy Will Become Decision Resources' Clinical Gold Standard in 2013 for the Treatment Of Gastric Cancer 4Health News:Roche/Genentech/Chugai's Herceptin as an Add-On to Standard Chemotherapy Will Become Decision Resources' Clinical Gold Standard in 2013 for the Treatment Of Gastric Cancer 5Health News:NxStage Announces New FREEDOM Data Showing the Positive Impact of its Daily Home Hemodialysis Therapy on Sleep Quality and Restless Legs Syndrome 2Health News:NxStage Announces New FREEDOM Data Showing the Positive Impact of its Daily Home Hemodialysis Therapy on Sleep Quality and Restless Legs Syndrome 3Health News:NxStage Announces New FREEDOM Data Showing the Positive Impact of its Daily Home Hemodialysis Therapy on Sleep Quality and Restless Legs Syndrome 4Health News:NxStage Announces New FREEDOM Data Showing the Positive Impact of its Daily Home Hemodialysis Therapy on Sleep Quality and Restless Legs Syndrome 5Health News:NxStage Announces New FREEDOM Data Showing the Positive Impact of its Daily Home Hemodialysis Therapy on Sleep Quality and Restless Legs Syndrome 6Health News:NxStage Announces New FREEDOM Data Showing the Positive Impact of its Daily Home Hemodialysis Therapy on Sleep Quality and Restless Legs Syndrome 7Health News:Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2009 Financial Results 2Health News:Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2009 Financial Results 3Health News:Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2009 Financial Results 4Health News:Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2009 Financial Results 5Health News:Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2009 Financial Results 6Health News:Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2009 Financial Results 7Health News:Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2009 Financial Results 8Health News:Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2009 Financial Results 9Health News:Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2009 Financial Results 10Health News:Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2009 Financial Results 11Health News:Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2009 Financial Results 12Health News:Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2009 Financial Results 13Health News:Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2009 Financial Results 14Health News:Chateau Amber Retreat Provides Specialized Post-Cosmetic Surgery Care in Palm Springs Luxury 2Health News:Chateau Amber Retreat Provides Specialized Post-Cosmetic Surgery Care in Palm Springs Luxury 3Health News:Chateau Amber Retreat Provides Specialized Post-Cosmetic Surgery Care in Palm Springs Luxury 4
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: